This website is intended for healthcare professionals only

Trending Topic

16 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Hypertension is the leading modifiable risk factor for global cardiovascular disease, responsible for an estimated 10.8 million deaths and more than 200 million disability-adjusted life years annually.1 Despite the availability of effective pharmacological and lifestyle interventions, prevalence continues to rise, particularly in low- and middle-income countries (LMICs), where over three-quarters of all cases now occur.2 The condition’s […]

19/Reduction in healthcare utilization associated with the use of ablation index guided pulmonary vein isolation

DG Gupta (Presenting Author) - Liverpool Heart and Chest Hospital, Liverpool; TH Hunter - Clinical Trial & Consulting, Covington; JV Vijgen - Virga Jessa Ziekenhuis, Hasselt; TD De Potter - Onze Lieve Vrouwziekenhuis Ziekenhuis Aalst-Asse-Ninove, Aalst; DS Scherr - Medical University Graz, Graz; HV Van Herendael - Ziekenhuis Oost – Limburg Campus, Genk; SK Knecht - AZ St Jan Brugge, Brugge; RK Kobza - Luzerner Kantonsspital Herzzentrum, Luzern; BB Berte - Luzerner Kantonsspital Herzzentrum, Luzern; NS Sandgaard - Odense University Hospital, Odense; JA Albenque - Clinique Pasteur, Toulouse; GS Szeplaki - Mater Private Hospital, Dublin; YJS Stevenhagen - Thoraxcentrum, Enschede; PT Taghji - Clinical Clairval Marseille, Marseille; MW Wright - St. Thomas Hospital London, London; MD Duytschaever - AZ St Jan Brugge, Brugge
< 1 min
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Sep 27th 2010 European Journal of Arrhythmia & Electrophysiology. 2020;6(Suppl. 1):abstr19
Select a Section…
1

Article

Background: Prior studies have shown that a standardized pulmonary vein isolation (PVI) workflow guided by a single ablation index (AI) value and a maximum interlesion distance (ILD) between corresponding ablation tags is associated with high single-procedure 1-year clinical success. Improvement in 1-year success may translate to lower cardiovascular healthcare utilization.

Purpose: To evaluate the effect of a standardized AI workflow in PAF ablation on cardiovascular healthcare utilization.

Methods: Patients were ablated for PAF in a prospective non-randomized clinical study across 17 European centres. Ablations followed a standard AI workflow (AI targets: 400 posterior, 550 anterior, ILD ≤6 mm) utilizing a contact force catheter, location stability settings of 2-3 mm for 3-5 s, 3 g force, and 25% force over time. Cardioversions and overnight cardiovascular hospitalizations were recorded for the 12-month periods pre- and post-ablation.

Results: A total of 329 patients were eligible and ablated with AI guidance (age 61 ± 10 years, 60.8% male, CHA2DS2-VASc 1.6 ± 1.4). Cardiovascular hospitalizations were reduced by 42% (99 to 57, p=0.0015) and cardioversions were reduced by 62% (77 to 29, p<0.0001) after ablation (Figure). The 57 post-ablation cardiovascular hospitalizations included 35 repeat ablations in 33 subjects (10%).

Conclusion: A standardized workflow incorporating AI guidance with a maximum ILD for PAF ablation resulted in a substantial reduction in cardiovascular hospitalization in the 12 months following ablation compared to the 12 months prior.

2

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup